Polymorphism of Filovirus Glycoproteins

Advances in Virus Research

Volumn 64, Issue , 2005, Pages 359-381

  Volchkov, Viktor E ^a   Volchkova, Valentina A ^a   Dolnik, Olga ^a   Feldmann, Heinz ^b   Klenk, Hans Dieter ^c  

^a UNIVERSITÉ LYON 1   (France)

^b Public Health Agency of Canada   (Canada)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; VIRUS ANTIGEN;

ANIMAL; ARTICLE; CHEMISTRY; FILOVIRIDAE; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; VIRION;

ANIMALS; ANTIGENS, VIRAL; FILOVIRIDAE; GLYCOPROTEINS; HUMANS; POLYMORPHISM, GENETIC; VIRION;

EID: 26944493447     PISSN: 00653527     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3527(05)64011-0     Document Type: Review

References (107)

1. Althoff K., Müllberg J., Aasland D., Voltz N., Kallen K.-J., Grötzinger J., and Rose-Hohn S. Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem. J. 35 (2001) 663-672
2. Althoff K., Reddy P., Voltz N., Rose-John S., and Müllberg J. Shedding of interleukin-6 receptor and tumor necrosis factor α: Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur. J. Biochem. 267 (2000) 2624-2631
3. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., and Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76 (2002) 6841-6844
4. Anderson E.D., Thomas L., Hayflick J.S., and Thomas G. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed 1-antitrypsin variant. J. Biol. Chem. 268 (1993) 24887-24891
5. Arribas J., López-Casillas F., and Massagué J. Role of the juxtamembrane domain of the transforming growth factor-α precursor and the β-amyloid precursor protein in regulated ectodomain shedding. J. Biol. Chem. 272 (1997) 17160-17165
6. Barr P.J., Mason O.B., Landsberg K.E., Wong P.A., Kiefer M.C., and Brake A.J. cDNA and gene structure for a human subtilisin-like protease with cleavage specificity for paired basic amino acid residues. DNA Cell Biol. 10 (1991) 319-328
7. Bashirova A.A., Geijtenbeek T.B., van Duijnhoven G.C., van Vliet S.J., Eilering J.B., Martin M.P., Wu L., Martin T.D., Viebig N., Knolle P.A., KewalRamani V.N., van Kooyk Y., and Carrington M. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J. Exp. Med. 193 (2001) 671-678
8. Basler C., and Palese P. Modulation of innate immunity by filoviruses. In: Klenk H.D., and Feldmann H. (Eds). "Ebola and Marburg Viruses: Molecular and Cellular Biology" (2004), Horizon Bioscience, Wymondham, UK 305-349
9. Bavari S., Bosio C.M., Wiegand E., Ruthel G., Will A.B., Geisbert T.W., Hevey M., Schmaljohn C., Schmaljohn A., and Aman M.J. Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195 (2002) 593-602
10. Becker S., Klenk H.-D., and Mühlberger E. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells. Virology 225 (1996) 145-155
11. Becker S., Spiess M., and Klenk H.-D. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J. Gen. Virol. 76 (1995) 393-399
12. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., and Cerretti D.P. A metalloproteinase desintegrin that release tumor-necrosis factor-α from cells. Nature 385 (1997) 729-733
13. Blobel C.P. Remarkable roles of proteolysis on and beyond the cell surface. Curr. Opin. Cell Biol. 12 (2000) 606-612
14. Blobel C.P., Wolfsberg T.G., Turck C.W., Myles D.G., Primakoff P., and White J.M. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356 (1992) 248-252
15. Boycott R., Klenk H.-D., and Ohuchi M. Cell tropism of influenza A virus mediated by hemagglutinin activation at the stage of virus entry. Virology 203 (1994) 313-319
16. Bray M. Pathogenesis of filovirus infection in mice. In: Klenk H.D., and Feldmann H. (Eds). "Ebola and Marburg Viruses: Molecular and Cellular Biology" (2004), Horizon Bioscience, Wymondham, UK 255-277
17. Bukreyev A.A., Volchkov V.E., Blinov V.M., Dryga S.A., and Netesov S.V. The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: A comparison with the Musoke 1980 strain. Arch. Virol. 140 (1995) 1589-1600
18. Bullough P.A., Hughson F.M., Skehel J.J., and Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371 (1994) 37-43
19. Buxbaum J.D., Liu K.-N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., and Black R.A. Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
20. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
21. Chan S.Y., Empig C.J., Welte F.J., Speck R.F., Schmaljohn A., Kreisberg J.F., and Goldsmith M.A. Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 106 (2001) 117-126
22. Chan S.Y., Ma M.C., and Goldsmith M.A. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Gen. Virol. 81 (2000) 2155-2159
23. Chan S.Y., Speck R.F., Ma M.C., and Goldsmith M.A. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol. 74 (2000) 4933-4937
24. Dolnik O., Volchkova V.A., Garten W., Carbonnelle C., Becker S., Kahnt J., Ströher U., Klenk H.-D., and Volchkov V.E. Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J. 23 (2004) 2175-2184
25. Ehlers M.R.W., Schwager S.L.U., Scholle R.R., Manji G.A., Brandt W.F., and Riordan J.F. Proteolytic release of membrane-bound angiotensin-converting enzyme: Role of the juxtamembrane stalk sequence. Biochemistry 35 (1996) 9549-9559
26. Feldmann H., Bugany H., Mahner F., Klenk H.-D., Drenckhahn D., and Schnittler H.J. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol. 70 (1996) 2208-2214
27. Feldmann H., Mühlberger E., Randolf A., Will C., Kiley M.P., Sanchez A., and Klenk H.-D. Marburg virus, a filovirus: Messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 24 (1992) 1-19
28. Feldmann H., Nichol S.T., Klenk H.-D., Peters C.J., and Sanchez A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199 (1994) 469-473
29. Feldmann H., Will C., Schikore M., Slenczka W., and Klenk H.-D. Glycosylation and oligomerization of the spike protein of Marburg virus. Virology 182 (1991) 353-356
30. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-877
31. Fisher-Hoch S.P., Brammer T.L., Trappier S.G., Hutwagner L.C., Farrar B.B., Ruo S.L., Brown B.G., Hermann L.M., Perez-Oronoz G.I., Goldsmith C.S., et al. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain. J. Infect. Dis. 166 (1992) 753-763
32. Funke C., Becker B., Dartsch H., Klenk H.-D., and Mühlberger E. Acylation of the Marburg virus glycoprotein. Virology 208 (1995) 289-297
33. Gallaher W.R. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses [letter]. Cell 85 (1996) 477-478
34. Garbutt M., Liebscher R., Wahl-Jensen V., Jones S., Möller P., Wagner R., Volchkov V., Klenk H.-D., Feldmann H., and Ströher U. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J. Virol. 78 (2004) 5458-5465
35. Geisbert T.W., and Jahrling P.B. Differentiation of filoviruses by electron microscopy. Virus Res. 39 (1995) 129-150
36. Geyer H., Will C., Feldmann H., Klenk H.-D., and Geyer R. Carbohydrate structure of Marburg virus glycoprotein. Glycobiology 2 (1992) 299-312
37. Hevey M., Negley D., Geisbert J., Jahrling P., and Schmaljohn A. Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants. Virology 239 (1998) 206-216
38. 1 integrin-dependent cell spreading. J. Cell Biol. 149 (2000) 1143-1156
39. Ignatyev G.M. Immune response to filovirus infections. Curr. Top. Microbiol. Immunol. 235 (1999) 205-217
40. Ito H., Watanabe S., Sanchez A., Whitt M.A., and Kawaoka Y. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J. Virol. 73 (1999) 8907-8912
41. Ito H., Watanabe S., Takada A., and Kawaoka Y. Ebola virus glycoprotein: Proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75 (2001) 1576-1580
42. Jeffers S.A., Sanders A.D., and Sanchez A. Covalent modifications of the Ebola virus glycoprotein. J. Virol. 76 (2002) 12463-12472
43. Joshi S.B., Dutch R.E., and Lamb R.A. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 248 (1998) 20-34
44. Kheramand F., and Werb Z. Shedding light on sheddases: Role in growth and development. Bioessays 24 (2002) 8-12
45. Killar L., White J., Black R., and Peschon J. Adamalysins. A family of metzincins including TNF-α converting enzyme (TACE). Ann. N.Y. Acad. Sci. 878 (1999) 442-452
46. Kindzelskii A.L., Yang Z., Nabel G.J., Todd III R.F., and Petty H.R. Ebola virus secretory glycoprotein (sGP) diminishes FcχRIIIB-to-CR3 proximity on neutrophils. J. Immunol. 164 (2000) 953-958
47. Klenk H.-D., and Garten W. Activation cleavage of viral spike proteins by host proteases. In: Wimmer E. (Ed). "Cellular Receptors for Animal Viruses" (1994), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 241-280
48. Klenk H.-D., Volchkov V.E., and Feldmann H. Two strings to the bow of Ebola virus. Nat. Med. 4 (1998) 388-389
49. Kolesnikova L., Berghöfer B., Bamberg S., and Becker S. Multivesicular bodies as a platform for the formation of Marburgvirus envelope. J. Virol. 78 (2004) 12277-12287
50. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., and Fahrenholz F. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96 (1999) 3922-3927
51. 2 from Ebola virus at 1.9-Å resolution. Proc. Natl. Acad. Sci. USA 96 (1999) 2662-2667
52. Mariyankova R.F., Giushakowa S.E., Pyzhik E.V., and Lukashevich I.S. Marburg virus penetration into eukaryotic cells. Vopr. Virusol. 2 (1993) 74-76
53. Maruyama T., Buchmeier M.J., Parren P.W., and Burton D.R. Ebola virus, neutrophils, and antibody specificity. Science 282 (1998) 845a
54. Maruyama T., Rodriguez L.L., Jahrling P.B., Sanchez A., Khan A.S., Nichol S.T., Petres C.J., Parren P.W., and Burton D.R. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J. Virol. 73 (1999) 6024-6030
55. Molloy S.S., Thomas L., van Slyke J.K., Stenberg P.E., and Thomas G. Intracellular trafficking and activation of the furin proprotein convertase: Localization to the TGN and recycling from the cell surface. EMBO J. 13 (1994) 18-33
56. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Cartner H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel. G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.L., Warner J., Willars D., and Becherer J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α. Nature 385 (1997) 733-736
57. Moss M.L., White J.M., Lambert M.H., and Andrews R.C. TACE and other ADAM proteases as targets for drug discovery. Drug Discov. Today 6 (2001) 417-426
58. Mupapa K.D., Massamba M., Kibadi K., Kuvula K., Bwaka A., Kipasa M., Colebunders R., Muyembe-Tamfum J.J., and on behalf of the International Scientific and Technical Committee. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J. Infect. Dis. 179 Suppl. 1 (1999) S18-S23
59. Nakayama K. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327 (1997) 625-635
60. Nakayama K., Kim W.-S., Torii S., Hosaka M., Nakagawa T., Ikemizu J., Baba T., and Murakami K. Identification of the fourth member of the mammalian endoprotease family homologous to the yeast Kex2 protease. J. Biol. Chem. 267 (1992) 5897-5900
61. Neumann G., Feldmann H., Watanabe S., Lukahevich I., and Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J. Virol. 76 (2002) 406-410
62. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., Boyce R.W., Nelson N., Kozlosky C.J., Wolfson M.F., Rauch C.T., Cerretti D.P., Paxton R.J., March C.J., and Black R.A. An essential role for ectodomain shedding in mammalian development. Science 282 (1998) 1281-1284
63. Pohlmann S., Baribaud F., Lee B., Leslie G.J., Sanchez M.D., Hiebenthal-Millow K., Munch J., Kirchhoff F., and Doms R.W. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J. Virol. 75 (2001) 4664-4672
64. Primakoff P., and Myles D.G. The ADAM gene family: Surface proteins with adhesion and protease activity. Trends Genet. 16 (2000) 63-87
65. Pushko P., Bray M., Ludwig G.V., Parker M., Schmaljohn A., Sanchez A., Jahrling P.B., and Smith J.F. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19 (2000) 142-153
66. Reddy P., Slack J.L., Davis R., Cerretti D.P., Kozlosky C.J., Blanton R.A., Shows D., Peschon J.J., and Black R.A. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J. Biol. Chem. 275 (2000) 14608-14614
67. Ruiz-Argüello M.B., Goni F.M., Pereira F.B., and Nieva J.L. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus. J. Virol. 72 (1998) 1775-1781
68. Sanchez A., Kiley M.P., Holloway B.P., and Auperin D.D. Sequence analysis of the Ebola virus genome: Organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29 (1993) 215-240
69. Sanchez A., Trappier S.G., Mahy B.W.J., Peters C.J., and Nichol S.T. The virion glycoprotein of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA 93 (1996) 3602-3607
70. Sanchez A., Trappier S.G., Ströher U., Nichol S.T., Bowen M.D., and Feldmann H. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology 240 (1998) 138-146
71. Sanchez A., Yang Z.Y., Xu L., Nabel G.J., Crews T., and Peters C.J. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72 (1998) 6442-6447
72. Sänger C., Mühlberger E., Lötfering B., Klenk H.-D., and Becker S. The Marburg virus surface protein GP is phosphorylated at its ectodomain. Virology 295 (2002) 20-29
73. Schäfer W., Stroh A., Berghöfer S., Seiler J., Vey M., Kruse M.L., Kern H.-F., Klenk H.-D., and Garten W. Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J. 14 (1995) 2424-2435
74. Schnittler H.J., and Feldmann H. Molecular pathogenesis of filovirus infections: Role of macrophages and endothelial cells. Curr. Top. Microbiol. Immunol. 235 (1999) 175-204
75. Seidah N.G., Hamelin J., Mamarbachi M., Dong W., Tadro H., Mbikay M., Chretien M., and Day R. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. Proc. Natl. Acad. Sci. USA 93 (1996) 3388-3393
76. Skehel J.J., Baylay P.M., Brown E.B., Martin S.R., Waterfield M.D., White J.M., Wilson I.A., and Wiley D.C. Changes in the conformation of the influenza hemagglutinin at the pH optimum of virus mediated membrane fusion. Proc. Natl. Acad. Sci. USA 79 (1982) 968-972
77. Stieneke-Gröber A., Vey M., Angliker H., Shaw E., Thomas G., Roberts C., Klenk H.-D., and Garten W. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11 (1992) 2407-2414
78. Ströher U., West E., Bugany H., Klenk H.D., Schnittler H.J., and Feldmann H. Infection and activation monocytes by Marburg and Ebola viruses. J. Virol. 75 (2001) 11025-11033
79. Sullivan N.J., Sanchez A., Rollin P.E., Yang Z.Y., and Nabel G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408 (2000) 605-609
80. Takada A., Robison C., Goto H., Sanchez A., Murti K.G., Whitt M.A., and Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA 94 (1997) 14764-14769
81. 1 integrins by Ebola virus glycoprotein: Implication for virus entry. Virology 278 (2000) 20-26
82. Van den Ouweland A.M.W., Duijnhoven H.P., Kreizer G.D., Dossers L.C.J., and Van de Ven W.J.M. Structural homology between the human fur gene product and the subtilisin-like protease encoded by yeast Kex2. Nucleic Acids Res. 18 (1990) 644
83. Vanderzanden L., Bray M., Fuller D., Roberts T., Custer D., Spik K., Jahrling P., Huggins J., Schmaljohn A., and Schmaljohn C. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology 246 (1998) 134-144
84. Van de Ven W.J., Voorberg J., Fontijn R., Pannekoek H., van den Ouweland A.M., van Duijnhoven H.L., Roebroek A.J., and Siezen R.J. Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes. Mol. Biol. Rep. 14 (1990) 265-275
85. Vey M., Schäfer W., Reis B., Ohuchi R., Britt W., Garten W., Klenk H.-D., and Radsak K. Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology 206 (1995) 746-749
86. Vidricaire G., Denault J.B., and Leduc R. Characterization of a secreted form of human furin endoprotease. Biochem. Biophys. Res. Commun. 195 (1993) 1011-1018
87. Volchkov V.E., Becker S., Volchkova V.A., Ternovoj V.A., Kotov A.N., Netesov S.V., and Klenk H.-D. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214 (1995) 421-430
88. Volchkov V.E., Blinov V.M., and Netesov S.V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 305 (1992) 181-184
89. Volchkov V.E., Chepurnov A.A., Volchkove V.A., Ternovoj V.A., and Klenk H.-D. Molecular characterization of guinea-pig-adapted variants of Ebola virus. Virology 277 (2000) 147-155
90. Volchkov V.E., Feldmann H., Volchkova V.A., and Klenk H.-D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 95 (1998) 5762-5767
91. Volchkov V.E., Volchkova V.A., Mühlberger E., Kolesnikova L.V., Weik M., Dolnik O., and Klenk H.-D. Recovery of infectious Ebola virus from complementary DAN: RNA editing of the GP gene and viral cytotoxicity. Science 291 (2001) 1965-1969
92. Volchkov V.E., Volchkova V.A., Slenczka W., Klenk H.-D., and Feldmann H. Release of viral glycoproteins during Ebola virus infection. Virology 245 (1998) 110-119
93. Volchkov V.E., Volchkova V.A., Ströher U., Cieplik M., Becker S., Dolnik O., Garten W., Klenk H.-D., and Feldmann H. Proteolytic processing of Marburg virus glycoprotein. Virology 268 (2000) 1-6
94. Volchkova V.A., Feldmann H., Klenk H.-D., and Volchkov V.E. The nonstructural small glycoprotein of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology 250 (1998) 408-414
95. Volchkova V., Klenk H.-D., and Volchkov V. Δ-Peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus. Virology 265 (1999) 64-171
96. Watanabe S., Takada A., Watanabe T., Ito H., Kida H., and Kawaoka Y. Functional importance of the coiled-coil of the Ebola virus glycoprotein. J. Virol. 74 (2000) 10194-10201
97. Weissenhorn W., Calder L.J., Wharton S.A., Skehel J.J., and Wiley D.C. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA 95 (1998) 6032-6036
98. 2, from the envelope glycoprotein ectodomain. Mol. Cell 2 (1998) 605-616
99. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., and Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 (1997) 426-430
100. Will C., Mühlberger E., Linder D., Slenczka W., Klenk H.-D., and Feldmann H. Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J. Virol. 67 (1993) 1203-1210
101. Wilson J.A., Hevey M., Bakken R., Guest S., Bray M., Schmaljohn A.L., and Hart M.K. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287 (2000) 1664-1666
102. Wool-Lewis R.J., and Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines. J. Virol. 72 (1998) 3155-3160
103. Wool-Lewis R.J., and Bates P. Endoproteolytic processing of the Ebola virus envelope glycoprotein: Cleavage is not required for function. J. Virol. 73 (1999) 1419-1426
104. Xu L., Sanchez A., Yang Z.Y., Zaki S.R., Nabel E.G., Nichol S.T., and Nabel G.J. Immunization for Ebola virus infection. Nat. Med. 4 (1998) 37-42
105. Yang Z., Delgado R., Xu L., Todd R.F., Nabek E.G., Sanchez A., and Nabel G.J. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 279 (1998) 1034-1036
106. Yang Z.-Y., Duckers H.J., Sullivan N.J., Sanchez A., Nabel E., and Nabel G.J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 8 (2000) 886-889
107. 3. J. Biol. Chem. 273 (1998) 7345-7350